26478675 | Aberrant expression of peroxiredoxin 1 and its clinical implications in liver cancer. | World J Gastroenterol | 2015 Oct 14 | Sun YL | doi: 10.3748/wjg.v21.i38.10840. |
23971998 | MicroRNA-510 promotes cell and tumor growth by targeting peroxiredoxin1 in breast cancer. | Breast Cancer Res | 2013 | Guo QJ | - |
21980378 | Proteomic analysis of ovarian cancer proximal fluids: validation of elevated peroxiredoxin 1 in patient peripheral circulation. | PLoS One | 2011 | Hoskins ER | doi: 10.1371/journal.pone.0025056 |
27503926 | SIRT2 Deacetylates and Inhibits the Peroxidase Activity of Peroxiredoxin-1 to Sensitize Breast Cancer Cells to Oxidant Stress-Inducing Agents. | Cancer Res | 2016 Sep 15 | Fiskus W | doi: 10.1158/0008-5472.CAN-16-0126 |
29673884 | Peroxiredoxin 1 promoted tumor metastasis and angiogenesis in colorectal cancer. | Pathol Res Pract | 2018 May | Li HX | doi: 10.1016/j.prp.2018.03.026 |
30886505 | MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation. | World J Gastroenterol | 2019 Mar 14 | Zhang Z | doi: 10.3748/wjg.v25.i10.1224. |
26170166 | The sulfiredoxin-peroxiredoxin (Srx-Prx) axis in cell signal transduction and cancer development. | Cancer Lett | 2015 Oct 1 | Mishra M | doi: 10.1016/j.canlet.2015.07.002 |
24297309 | Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma. | Med Oncol | 2014 Jan | Sun QK | doi: 10.1007/s12032-013-0786-2 |
23914992 | Proteomic analysis of non-small cell lung cancer tissue interstitial fluids. | World J Surg Oncol | 2013 Aug 5 | Li S | doi: 10.1186/1477-7819-11-173. |
26636537 | Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma. | Oncotarget | 2016 Jan 12 | Trzeciecka A | doi: 10.18632/oncotarget.6435. |
21343392 | Peroxiredoxin 1 controls prostate cancer growth through Toll-like receptor 4-dependent regulation of tumor vasculature. | Cancer Res | 2011 Mar 1 | Riddell JR | doi: 10.1158/0008-5472.CAN-10-3674 |
29656298 | High Expression of Peroxiredoxin 1 Is Associated with Epithelial-Mesenchymal Transition Marker and Poor Prognosis in Gastric Cancer. | Med Sci Monit | 2018 Apr 15 | Yu W | - |
14703116 | Preferential elevation of Prx I and Trx expression in lung cancer cells following hypoxia and in human lung cancer tissues. | Cell Biol Toxicol | 2003 Oct | Kim HJ | - |
23615915 | Prx1 modulates the chemosensitivity of lung cancer to docetaxel through suppression of FOXO1-induced apoptosis. | Int J Oncol | 2013 Jul | Hwang KE | doi: 10.3892/ijo.2013.1918 |
22215146 | Polymorphisms of peroxiredoxin 1, 2 and 6 are not associated with esophageal cancer. | J Cancer Res Clin Oncol | 2012 Apr | Zhang B | doi: 10.1007/s00432-011-1119-5 |
18549262 | Proteomic expression analysis of surgical human colorectal cancer tissues: up-regulation of PSB7, PRDX1, and SRP9 and hypoxic adaptation in cancer. | J Proteome Res | 2008 Jul | Rho JH | doi: 10.1021/pr8000892 |
25162226 | Induction of peroxiredoxin 1 by hypoxia regulates heme oxygenase-1 via NF-??B in oral cancer. | PLoS One | 2014 Aug 27 | Zhang M | doi: 10.1371/journal.pone.0105994 |
23113308 | Expression of peroxiredoxin 1, 2, 3, and 6 genes in cancer cells during drug resistance formation. | Bull Exp Biol Med | 2012 Oct | Kalinina EV | - |
17606720 | Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer. | Clin Cancer Res | 2007 Jul 1 | Kim JH | - |
23277276 | Proteomics in HepG2 hepatocarcinoma cells with stably silenced expression of PRDX1. | J Proteomics | 2013 Feb 21 | Aguilar-Melero P | doi: 10.1016/j.jprot.2012.12.005 |
20631257 | Selective association of peroxiredoxin 1 with genomic DNA and COX-2 upstream promoter elements in estrogen receptor negative breast cancer cells. | Mol Biol Cell | 2010 Sep 1 | Wang X | doi: 10.1091/mbc.E10-02-0160 |
26689287 | PRX1 knockdown potentiates vitamin K3 toxicity in cancer cells: a potential new therapeutic perspective for an old drug. | J Exp Clin Cancer Res | 2015 Dec 21 | He T | doi: 10.1186/s13046-015-0270-2. |
22537621 | Peroxiredoxins and tropomyosins as plasma biomarkers for lung cancer and asbestos exposure. | Lung Cancer | 2012 Aug | Rostila A | doi: 10.1016/j.lungcan.2012.03.024 |
16278420 | Histone deacetylase inhibitor FK228 activates tumor suppressor Prdx1 with apoptosis induction in esophageal cancer cells. | Clin Cancer Res | 2005 Nov 1 | Hoshino I | - |
23065574 | ILK and PRDX1 are prognostic markers in squamous cell/adenosquamous carcinomas and adenocarcinoma of gallbladder. | Tumour Biol | 2013 Feb | Li J | doi: 10.1007/s13277-012-0557-2 |
19902980 | Proteomic identification of overexpressed PRDX 1 and its clinical implications in ovarian carcinoma. | J Proteome Res | 2010 Jan | Chung KH | doi: 10.1021/pr900811x. |
25011585 | Peroxiredoxin-1 protects estrogen receptor α from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer. | Breast Cancer Res | 2014 Jul 10 | O'Leary PC | doi: 10.1186/bcr3691. |
27388124 | Peroxiredoxin 1 interacts with and blocks the redox factor APE1 from activating interleukin-8 expression. | Sci Rep | 2016 Jul 8 | Nassour H | doi: 10.1038/srep29389. |